Mondelez International Valuation
Is MDLZ * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MDLZ * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MDLZ * (MX$1206.9) is trading below our estimate of fair value (MX$1658.81)
Significantly Below Fair Value: MDLZ * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MDLZ *?
Other financial metrics that can be useful for relative valuation.
What is MDLZ *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$91.78b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3x |
Enterprise Value/EBITDA | 13.1x |
PEG Ratio | 3.8x |
Price to Earnings Ratio vs Peers
How does MDLZ *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 15.3x | ||
BIMBO A Grupo Bimbo. de | 20.7x | 12.2% | Mex$281.6b |
GRUMA B Gruma. de | 15x | 6.8% | Mex$121.1b |
BACHOCO B Industrias Bachoco. de | 14x | n/a | Mex$50.9b |
BAFAR B Grupo Bafar. de | 11.4x | n/a | Mex$36.3b |
MDLZ * Mondelez International | 21.2x | 5.5% | Mex$91.8b |
Price-To-Earnings vs Peers: MDLZ * is expensive based on its Price-To-Earnings Ratio (21.2x) compared to the peer average (15.3x).
Price to Earnings Ratio vs Industry
How does MDLZ *'s PE Ratio compare vs other companies in the South American Food Industry?
Price-To-Earnings vs Industry: MDLZ * is expensive based on its Price-To-Earnings Ratio (21.2x) compared to the South American Food industry average (10.6x).
Price to Earnings Ratio vs Fair Ratio
What is MDLZ *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 21.2x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MDLZ *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,206.90 | Mex$1,440.51 +19.4% | 5.0% | Mex$1,617.05 | Mex$1,311.61 | n/a | 24 |
Jun ’25 | n/a | Mex$1,380.01 0% | 4.3% | Mex$1,526.91 | Mex$1,272.43 | n/a | 24 |
May ’25 | Mex$1,239.27 | Mex$1,387.23 +11.9% | 4.7% | Mex$1,531.60 | Mex$1,242.30 | n/a | 24 |
Apr ’25 | Mex$1,164.11 | Mex$1,382.00 +18.7% | 4.1% | Mex$1,480.20 | Mex$1,214.10 | n/a | 25 |
Mar ’25 | Mex$1,255.00 | Mex$1,416.21 +12.8% | 4.1% | Mex$1,514.66 | Mex$1,242.36 | n/a | 25 |
Feb ’25 | Mex$1,298.00 | Mex$1,412.92 +8.9% | 4.5% | Mex$1,520.70 | Mex$1,247.31 | n/a | 25 |
Jan ’25 | Mex$1,222.50 | Mex$1,367.18 +11.8% | 5.5% | Mex$1,519.17 | Mex$1,177.78 | n/a | 24 |
Dec ’24 | n/a | Mex$1,371.01 0% | 6.0% | Mex$1,540.91 | Mex$1,194.64 | n/a | 23 |
Nov ’24 | Mex$1,198.00 | Mex$1,401.59 +17.0% | 7.7% | Mex$1,585.29 | Mex$1,157.80 | n/a | 22 |
Oct ’24 | Mex$1,206.00 | Mex$1,453.20 +20.5% | 5.4% | Mex$1,573.83 | Mex$1,237.85 | n/a | 23 |
Sep ’24 | Mex$1,190.00 | Mex$1,408.72 +18.4% | 5.3% | Mex$1,517.43 | Mex$1,193.49 | n/a | 21 |
Aug ’24 | Mex$1,241.00 | Mex$1,394.59 +12.4% | 5.3% | Mex$1,500.66 | Mex$1,180.29 | n/a | 21 |
Jul ’24 | n/a | Mex$1,379.86 0% | 5.2% | Mex$1,468.58 | Mex$1,195.36 | n/a | 21 |
Jun ’24 | Mex$1,281.00 | Mex$1,456.12 +13.7% | 5.3% | Mex$1,546.10 | Mex$1,258.45 | n/a | 21 |
May ’24 | Mex$1,397.00 | Mex$1,428.44 +2.3% | 6.4% | Mex$1,541.86 | Mex$1,237.07 | Mex$1,239.27 | 23 |
Apr ’24 | Mex$1,275.00 | Mex$1,401.51 +9.9% | 4.5% | Mex$1,505.86 | Mex$1,298.80 | Mex$1,164.11 | 23 |
Mar ’24 | Mex$1,200.00 | Mex$1,423.37 +18.6% | 4.8% | Mex$1,532.31 | Mex$1,264.16 | Mex$1,255.00 | 24 |
Feb ’24 | Mex$1,232.93 | Mex$1,378.73 +11.8% | 5.1% | Mex$1,489.68 | Mex$1,228.99 | Mex$1,298.00 | 24 |
Jan ’24 | Mex$1,296.00 | Mex$1,416.88 +9.3% | 4.4% | Mex$1,512.65 | Mex$1,296.56 | Mex$1,222.50 | 24 |
Dec ’23 | Mex$1,311.40 | Mex$1,375.92 +4.9% | 3.7% | Mex$1,472.36 | Mex$1,278.63 | n/a | 23 |
Nov ’23 | Mex$1,247.32 | Mex$1,376.02 +10.3% | 5.1% | Mex$1,486.08 | Mex$1,248.31 | Mex$1,198.00 | 22 |
Oct ’23 | Mex$1,170.00 | Mex$1,455.95 +24.4% | 4.9% | Mex$1,593.68 | Mex$1,291.08 | Mex$1,206.00 | 22 |
Sep ’23 | n/a | Mex$1,456.98 0% | 4.8% | Mex$1,589.39 | Mex$1,287.60 | Mex$1,190.00 | 21 |
Aug ’23 | Mex$1,290.00 | Mex$1,478.33 +14.6% | 4.4% | Mex$1,610.34 | Mex$1,284.20 | Mex$1,241.00 | 21 |
Jul ’23 | Mex$1,238.67 | Mex$1,472.41 +18.9% | 4.2% | Mex$1,579.16 | Mex$1,275.48 | n/a | 22 |
Jun ’23 | Mex$1,250.00 | Mex$1,448.57 +15.9% | 4.7% | Mex$1,556.13 | Mex$1,256.88 | Mex$1,281.00 | 23 |
Analyst Forecast: Target price is less than 20% higher than the current share price.